DelveInsight’s Spasticity Market Insights, Epidemiology, and Market Forecast-2032″ Report delivers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Spasticity market report provides current treatment practices, emerging drugs, Spasticity market share of the individual therapies, and current and forecasted Spasticity market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Spasticity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of opportunities and assesses the underlying potential of the Spasticity market.
Some of the key facts of the Spasticity Market Report
- According to Pal (2014), Spasticity occurs at a variable rate among patients with Multiple sclerosis (78%), stroke (35%), Traumatic brain injury (50%), Cerebral palsy (90%), and Spinal cord injury (40%). Therapies for Spasticity include medications, rehabilitation, local injections, surgery, and occupational and physical therapy programs.
- Gender-specific Epidemiology of Spasticity As per DelveInsight’s estimates, there were approximately 2,328,000 prevalent cases of Spasticity in the United States in 2021. The number of prevalent cases of patients at risk of Spasticity due to Multiple Sclerosis and Cerebral Palsy in 2021 were ~443,000 and ~552,000 respectively in the United States.
- As per a study conducted by Kuo and Hu (2018), Spasticity is common after stroke, with the prevalence ranging from 30% to 80% of stroke survivors. Martin et al. (2014).
Key benefits of the Spasticity Market report:
- The report covers the descriptive overview of Spasticity, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Spasticity epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Spasticity is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of the Spasticity market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Spasticity market
Got queries? Click here to know more about the Spasticity Market Landscape
Spasticity Overview
Spasticity is defined as a “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflexes with exaggerated tender jerks, resulting from hyperexcitability of the stretch refluxes or from upper motor neuron presenting involuntary activations of the muscles.
Diagnosis – Neurological Testing can be done to determine the severity. MRI can be done to determine the source and the damage caused due to the disease.
Most common symptom for multiple sclerosis seen in 90%of patients
Spasticity Market Epidemiological Segmentation
- Total Spasticity prevalent cases based on condition
- Total Spasticity diagnosed prevalent cases
- Total Spasticity treatable prevalent cases
Spasticity Market Outlook
The Spasticity market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Spasticity market trends by analyzing the impact of current Spasticity therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of Spasticity market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Spasticity market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Spasticity market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @Spasticity Market Market Landscape
Spasticity Market Key Companies
- Jazz Pharmaceuticals
- Revance Therapeutics
- Ipsen
- And many more
Spasticity Market Therapies
- Nabiximols
- DAXI
- IPN10200
- And many more
Table of Contents
- Key Insights
- Report Introduction
- Executive Summary of Spasticity Market
- Disease Background and Overview
- Epidemiology and patient population
- The United States
- EU 5
- Spasticity Market Emerging Therapies
- Spasticity Market Market Outlook
- Market Access and Reimbursement of Therapies
- Appendix
- Spasticity Market Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsi
Click here to read more about Spasticity Market Landscape
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/